Suppr超能文献

联合抗逆转录病毒疗法可改善未经治疗的 HIV 感染者的认知表现和功能连接。

Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.

机构信息

Department of Electrical and Computer Engineering, University of Rochester, Rochester, NY, USA.

Department of Biostatistics and Computational Biology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

J Neurovirol. 2017 Oct;23(5):704-712. doi: 10.1007/s13365-017-0553-9. Epub 2017 Aug 8.

Abstract

UNLABELLED

Our study aimed to investigate the short-term effect of combination antiretroviral therapy (cART) on cognitive performance and functional and structural connectivity and their relationship to plasma levels of antiretroviral (ARV) drugs. Seventeen ARV treatment-naïve HIV-infected individuals (baseline mean CD4 cell count, 479 ± 48 cells/mm) were age matched with 17 HIV-uninfected individuals. All subjects underwent a detailed neurocognitive and functional assessment and magnetic resonance imaging. HIV-infected subjects were scanned before starting cART and 12 weeks after initiation of treatment. Uninfected subjects were assessed once at baseline. Functional connectivity (FC) was assessed within the default mode network while structural connectivity was assessed by voxel-wise analysis using tract-based spatial statistics (TBSS) and probabilistic tractography within the DMN. Tenofovir and emtricitabine blood concentration were measured at week 12 of cART. Prior to cART, HIV-infected individuals had significantly lower cognitive performance than control subjects as measured by the total Z-score from the neuropsychological tests assessing six cognitive domains (p = 0.020). After 12 weeks of cART treatment, there remained only a weak cognitive difference between HIV-infected and HIV-uninfected subjects (p = 0.057). Mean FC was lower in HIV-infected individuals compared with those uninfected (p = 0.008), but FC differences became non-significant after treatment (p = 0.197). There were no differences in DTI metrics between HIV-infected and HIV-uninfected individuals using the TBSS approach and limited evidence of decreased structural connectivity within the DMN in HIV-infected individuals. Tenofovir and emtricitabine plasma concentrations did not correlate with either cognitive performance or imaging metrics.

CONCLUSIONS

Twelve weeks of cART improves cognitive performance and functional connectivity in ARV treatment-naïve HIV-infected individuals with relatively preserved immune function. Longer periods of observation are necessary to assess whether this effect is maintained.

摘要

未标注

本研究旨在探究联合抗逆转录病毒疗法(cART)对认知表现、功能和结构连接的短期影响,以及这些因素与抗逆转录病毒(ARV)药物的血浆水平之间的关系。17 名接受 ARV 治疗的初治 HIV 感染者(基线平均 CD4 细胞计数为 479±48 个细胞/mm)与 17 名 HIV 未感染者相匹配。所有受试者均接受详细的神经认知和功能评估以及磁共振成像检查。HIV 感染者在开始 cART 前和治疗开始后 12 周进行扫描。未感染者仅在基线时评估一次。在默认模式网络中评估功能连接(FC),并通过基于体素的空间统计学(TBSS)和默认模式网络内的概率性轨迹追踪,对结构连接进行分析。在 cART 的第 12 周测量替诺福韦和恩曲他滨的血药浓度。在 cART 之前,HIV 感染者的认知表现明显低于对照组,表现在评估六个认知域的神经心理学测试的总 Z 分数上(p=0.020)。在 cART 治疗 12 周后,HIV 感染者与 HIV 未感染者之间仍存在微弱的认知差异(p=0.057)。与未感染者相比,HIV 感染者的平均 FC 较低(p=0.008),但治疗后 FC 差异无统计学意义(p=0.197)。使用 TBSS 方法,HIV 感染者和 HIV 未感染者之间的 DTI 指标没有差异,并且在 HIV 感染者中仅有限证据表明 DMN 内的结构连接减少。替诺福韦和恩曲他滨的血浆浓度与认知表现或影像学指标均无相关性。

结论

在具有相对较好免疫功能的初治 HIV 感染者中,12 周的 cART 可改善认知表现和功能连接。需要进行更长时间的观察以评估这种效果是否得以维持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/5655604/a7bc7376938b/13365_2017_553_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验